What is New in Myelodysplastic Syndrome?
Hagop M. Kantarjian, MD, Chairman, Leukemia Department, M.D. Anderson Cancer Center

Emerging Therapies for Non-Hodgkin's Lymphoma (NHL): Update from ASCO 2006 and ASH 2005
David G. Maloney, MD, PhD - Fred Hutchinson Cancer Research Center

Mucosal Toxicities Associated With Conditioning Regimens for Hematopoietic Stem Cell Transplantation
Stephen T. Sonis, DMD, DMSc
Dana Farber Cancer Institute, Brigham and Women's Hospital, Harvard School of Dental Medicine

What Is New in Multiple Myeloma?
Frits van Rhee, MD, PhD
Myeloma Institute for Research and Therapy, University of Arkansas

Progress in Supportive Care – American Society of Hematology Meeting 2005
Charles H. Weaver, MD

Targeted Therapy for Patients With Chronic Myeloid Leukemia: Proceedings From ASH 2005
C. Dean Buckner, MD

Cord Blood Transplantation in the Management of Malignancies
Nelson J. Chao, MD, MBA
Chief, Division of Cellular Therapy/BMT, Duke University